TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16219013

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily plus a diet providing an energy deficit of 500 kcal/day
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily plus a diet providing an energy deficit of 1000 kcal/day
Number of subjects: 430

Group type: COMPARATOR
Intervention: Both diet treatment groups (500 kcal/day and 1000 kcal/day)
Number of subjects: 430
Study: 12355350

Group type: EXPERIMENTAL
Intervention: Glossodynia patients
Number of subjects: 17
Study: 10036559

Group type: EXPERIMENTAL
Intervention: Self-management educational program
Number of subjects: 29
Study: 7552617

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) with doses of 12.5-16.5 Gy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Adjuvant external beam radiation (given to 23 of the 27 patients receiving IORT) with total doses ranging from 24 to 50 Gy
Number of subjects: 43
Study: 1527129

Group type: EXPERIMENTAL
Intervention: prefabricated functional brace
Number of subjects: 39

Group type: COMPARATOR
Intervention: long-arm cast
Number of subjects: 39
Study: 2410720

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg (hypertension group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg (hypertension group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enalapril (congestive heart failure group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: MK 422 (metabolite)
Number of subjects: 13
Study: 31046527

Group type: EXPERIMENTAL
Intervention: Tele-education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (delayed tele-education)
Number of subjects: 0
Study: 29410329

Group type: EXPERIMENTAL
Intervention: Novel sheath group
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 27581208

Group type: EXPERIMENTAL
Intervention: initial triple DMARD therapy (iTDT) with glucocorticoids (GCs) intramuscular
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: initial triple DMARD therapy (iTDT) with an oral GC tapering scheme
Number of subjects: 281

Group type: COMPARATOR
Intervention: initial MTX monotherapy (iMM) with GCs
Number of subjects: 281
Study: 26717392

Group type: EXPERIMENTAL
Intervention: Dietary intake (DI) group
Number of subjects: 30
Study: 24027184

Group type: EXPERIMENTAL
Intervention: Total n-3 PUFAs (including ALA, EPA, DPA, DHA)
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Total n-6 PUFAs (including linoleic acid and arachidonic acid)
Number of subjects: 843
Study: 21262345

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 39
Study: 18306849

Group type: EXPERIMENTAL
Intervention: Minimally invasive treatment modalities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 0
Study: 16835528

Group type: EXPERIMENTAL
Intervention: Silver alloy-coated Foley catheters
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard catheters (pre-intervention)
Number of subjects: 117
Study: 12892607

Group type: EXPERIMENTAL
Intervention: Laser capsulotomy with 2 mm diameter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laser capsulotomy with 4 mm diameter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transparent posterior capsule group
Number of subjects: 40
Study: 10975771

Group type: EXPERIMENTAL
Intervention: High dose recombinant alpha-2a interferon (9 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low dose recombinant alpha-2a interferon (6 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: One log viral load decrease at 2 or 4 weeks
Number of subjects: 53
Study: 7847866

Group type: EXPERIMENTAL
Intervention: 5% lidocaine gel applied locally to painful skin area
Number of subjects: 39

Group type: COMPARATOR
Intervention: Remote application of lidocaine gel to mirror-image skin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Vehicle applied bilaterally (placebo)
Number of subjects: 39
Study: 2128266

Group type: EXPERIMENTAL
Intervention: Standard continuous total parenteral nutrition (S-TPN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cyclic total parenteral nutrition (C-TPN)
Number of subjects: 20
Study: 7013403

Group type: EXPERIMENTAL
Intervention: Cimetidine (1,200 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31149873

Group type: EXPERIMENTAL
Intervention: Bottom-vented canisters in horizontal position at high isoflurane flow rate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Top-vented canisters in horizontal position at high isoflurane flow rate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vertical position of charcoal air-filtration canisters
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Canister elevation relative to the vaporizer
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Position of canisters (vertical vs horizontal)
Number of subjects: 24
Study: 28121466

Group type: EXPERIMENTAL
Intervention: 20-week trauma-sensitive yoga treatment
Number of subjects: 9
Study: 25421015

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 54
Study: 23464935

Group type: EXPERIMENTAL
Intervention: InterTan nail
Number of subjects: 132

Group type: COMPARATOR
Intervention: PFNA‐II
Number of subjects: 132
Study: 21255955

Group type: EXPERIMENTAL
Intervention: Wireless remote monitoring with automatic clinician alerts
Number of subjects: 1997

Group type: COMPARATOR
Intervention: Standard in-office care
Number of subjects: 1997
Study: 18956132

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN, 70 mg/week) plus calcium (500 mg/daily) and vitamin D(3) (400 IU/daily)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Calcium (500 mg/daily) and vitamin D(3) (400 IU/daily; Ca-Vit D group)
Number of subjects: 239
Study: 17050216

Group type: COMPARATOR
Intervention: Conventional dosing schedule (tablet phenytoin 100-400 mg/day OD or BD, tablet carbamazepine 200-800 mg BD, or both)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Chronotherapeutic dosing schedule (shift of daily dose to 20:00 h)
Number of subjects: 103
Study: 14656363

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) Turbohaler 1600 mcg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10705771

Group type: EXPERIMENTAL
Intervention: Viewing different pictures at two assessments separated by 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viewing the same pictures at both assessments
Number of subjects: 0
Study: 9137496

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg + Ondansetron 8 mg x 3
Number of subjects: 105
Study: 8121429

Group type: EXPERIMENTAL
Intervention: Bed alarm system (experimental group, n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No intervention (control group, n = 35)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Bed alarm system (experimental group)
Number of subjects: 70
Study: 2441175

Group type: EXPERIMENTAL
Intervention: 200 mg acebutolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50 mg atenolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 mg betaxolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 100 mg metoprolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29574866

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: No enamel matrix derivative (non-EMD)
Number of subjects: 29
Study: 26705893

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 36
Study: 25907080

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 1861

Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 1861
Study: 23400742

Group type: EXPERIMENTAL
Intervention: etravirine 200 mg twice daily with fluconazole 200 mg daily
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: etravirine 200 mg twice daily with voriconazole 200 mg twice daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: fluconazole alone
Number of subjects: 18

Group type: COMPARATOR
Intervention: voriconazole alone
Number of subjects: 18
Study: 20493604

Group type: EXPERIMENTAL
Intervention: Chairside computers
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Calling per diem staff
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Nurse competency examinations
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Technician cannulation mastery
Number of subjects: 423
Study: 18758284

Group type: EXPERIMENTAL
Intervention: Early treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Delayed treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes for all cases.
Number of subjects: 12
Study: 16394298

Group type: EXPERIMENTAL
Intervention: HRV vaccine (31,673 infants)
Number of subjects: 63225

Group type: COMPARATOR
Intervention: Placebo (31,552 infants)
Number of subjects: 63225
Study: 12868787

Group type: EXPERIMENTAL
Intervention: Cardioplegic leucocyte depletion (CLD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total leucocyte depletion (TLD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Systemic leucocyte depletion (SLD)
Number of subjects: 40
Study: 10977379

Group type: EXPERIMENTAL
Intervention: Heart Attack Survival Kit via home visit by EMT
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Heart Attack Survival Kit via direct mail
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Combined intervention group (EMT and direct mail)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1200
Study: 8852392

Group type: EXPERIMENTAL
Intervention: Nefazodone combined with digoxin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nefazodone alone
Number of subjects: 18
Study: 1503094

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐N1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Splenectomy
Number of subjects: 20
Study: 6327926

Group type: EXPERIMENTAL
Intervention: Neocarzinostatin (NCZ)
Number of subjects: 61

Group type: COMPARATOR
Intervention: m-AMSA
Number of subjects: 61

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 61
Study: 31552797

Group type: EXPERIMENTAL
Intervention: Genomic information with supportive communication
Number of subjects: 168

Group type: COMPARATOR
Intervention: Behavioral information
Number of subjects: 168
Study: 29621896

Group type: EXPERIMENTAL
Intervention: Emotional support seeking
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Felt stigma
Number of subjects: 744
Study: 26626808

Group type: EXPERIMENTAL
Intervention: Fall injuries
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Fall injuries among elderly (≥65 years)
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Fall injuries among children (<15 years)
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Fall injuries among adults (15-64 years)
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Respondents spending significant time at home
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Life-limiting disability due to fall injuries
Number of subjects: 5148

Group type: EXPERIMENTAL
Intervention: Financial hardship after fall injuries
Number of subjects: 5148
Study: 25895196

Group type: EXPERIMENTAL
Intervention: Maternal education about appropriate complementary feeding (CF) delivered through three education modules at baseline and two subsequent visits 10 weeks apart.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group received advice about breastfeeding (BF) according to national guidelines.
Number of subjects: 0
Study: 23405792

Group type: EXPERIMENTAL
Intervention: Compound Xuanju Capsule plus vitamin E
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vitamin E (Control)
Number of subjects: 50
Study: 19579641

Group type: EXPERIMENTAL
Intervention: famotidine 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: lansoprazole 30 mg
Number of subjects: 12
Study: 17502549

Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15170874

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (0.5 mg/kg/day for 3 days, 0.25 mg/kg/day for 3 days, 0.1 mg/kg/day on day 7; total dose 2.35 mg/kg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (0.2 mg/kg/day for 3 days and 0.1 mg/kg/day for 4 days; total dose 1 mg/kg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Comparison between high-dose and low-dose dexamethasone
Number of subjects: 62
Study: 15305783

Group type: EXPERIMENTAL
Intervention: Annual screening for fecal occult blood
Number of subjects: 235000

Group type: EXPERIMENTAL
Intervention: Biennial screening for fecal occult blood
Number of subjects: 235000

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 235000
Study: 9854132

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open hernia repair
Number of subjects: 0
Study: 8092087

Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 0 mg cystine.kg‐1.d‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 5.2 mg cystine.kg‐1.d‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 10.5 mg cystine.kg‐1.d‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 20.9 mg cystine.kg‐1.d‐1
Number of subjects: 8

Group type: COMPARATOR
Intervention: 13 mg methionine.kg‐1.d‐1 without cystine
Number of subjects: 8
Study: 2643866

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 36
Study: 31880338

Group type: EXPERIMENTAL
Intervention: MDTP + NMES
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MDTP
Number of subjects: 53

Group type: COMPARATOR
Intervention: MDTP + sham NMES
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care (UC) swallowing therapy
Number of subjects: 53
Study: 30565191

Group type: EXPERIMENTAL
Intervention: Interval walking training (IWT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal walking training (NWT)
Number of subjects: 68
Study: 28561762

Group type: EXPERIMENTAL
Intervention: Dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (milk)
Number of subjects: 200
Study: 25167796

Group type: EXPERIMENTAL
Intervention: Linear array EUS training after radial-scanning EUS training (Group A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Linear array EUS training alone (Group B)
Number of subjects: 18
Study: 23819675

Group type: EXPERIMENTAL
Intervention: Treatment with sparse verbs
Number of subjects: 6

Group type: COMPARATOR
Intervention: Treatment with dense verbs
Number of subjects: 6
Study: 21365055

Group type: EXPERIMENTAL
Intervention: ITI (Institut Straumann) implants
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SwissPlus (Zimmer Dental) implants
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Astra (Astra Tech) implants
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 36
Study: 19801020

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 30,000 IU intravenously before tenecteplase treatment
Number of subjects: 236

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 236
Study: 17114905

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided laser photocoagulation (PLP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 26
Study: 14748786

Group type: EXPERIMENTAL
Intervention: Rapid pre-screen
Number of subjects: 75355

Group type: COMPARATOR
Intervention: No pre-screen
Number of subjects: 75355

Group type: EXPERIMENTAL
Intervention: Routine laboratory practice with rapid pre-screen
Number of subjects: 75355
Study: 11491426

Group type: EXPERIMENTAL
Intervention: Donjoy custom‐fit ACL brace (CE 2000)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Donjoy off‐the‐shelf brace (Goldpoint)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Athletic taping technique
Number of subjects: 5
Study: 9413414

Group type: EXPERIMENTAL
Intervention: Sertraline (50‐200 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline (50‐150 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8501272

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/fluoride dentifrice
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional fluoride containing dentifrice
Number of subjects: 120
Study: 3781184

Group type: EXPERIMENTAL
Intervention: Cisapride (5 mg) intravenously 15 min before meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg) intravenously 15 min before meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29660018

Group type: EXPERIMENTAL
Intervention: IDES cases (n = 159)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group (n = 163)
Number of subjects: 322
Study: 27118539

Group type: EXPERIMENTAL
Intervention: PCT group: length of ATB guided by institutional protocol plus PCT dynamics
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: PCT group
Number of subjects: 62
Study: 25495315

Group type: EXPERIMENTAL
Intervention: Polypill strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 22008208

Group type: EXPERIMENTAL
Intervention: 24% O(2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: CA
Number of subjects: 35
Study: 20156348

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy using FloTrac/Vigileo device (GDT-group, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard management protocol (Control-group, n = 30)
Number of subjects: 60
Study: 18576310

Group type: EXPERIMENTAL
Intervention: Internet-based Arthritis Self-Management Program (ASMP)
Number of subjects: 855

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 855
Study: 16260965

Group type: EXPERIMENTAL
Intervention: High-intensity PRMST (>=80% 1RM)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low-resistance exercise (20% of the 1RM)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Testosterone (100 mg of testosterone enanthate)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High-intensity PRMST
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low-resistance exercise
Number of subjects: 71
Study: 11877261

Group type: EXPERIMENTAL
Intervention: Intravenous anti-D
Number of subjects: 28
Study: 10096265

Group type: EXPERIMENTAL
Intervention: 200 mg oral modafinil in the morning and 100 mg at midday
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7781199

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 0.6 mg/kg IV as Solu‐Medrol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 6
Study: 2228544

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 160
Study: 6104384

Group type: EXPERIMENTAL
Intervention: Somatostatin infusion (500 micrograms/h) with active fungal lipase (150,000 E)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Somatostatin infusion (500 micrograms/h) with placebo capsules
Number of subjects: 7
Study: 31841475

Group type: EXPERIMENTAL
Intervention: Intra-arterial polychemotherapy (IA PCT) prior to radiotherapy
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Systemic radiochemotherapy with polyplatilen
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Induction polychemotherapy with polyplatilen
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Radiothermic personalisation
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Intra-arterial polychemotherapy followed by radiotherapy
Number of subjects: 280
Study: 28349328

Group type: EXPERIMENTAL
Intervention: Doravirine 100 mg alone
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Doravirine FDC (with lamivudine and tenofovir disoproxil fumarate)
Number of subjects: 28
Study: 26471136

Group type: EXPERIMENTAL
Intervention: Aut‐A
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aut‐B
Number of subjects: 4

Group type: COMPARATOR
Intervention: HC
Number of subjects: 4

Group type: COMPARATOR
Intervention: MA
Number of subjects: 4
Study: 24528997

Group type: EXPERIMENTAL
Intervention: School-based inhaled corticosteroid treatment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 74
Study: 22932809

Group type: EXPERIMENTAL
Intervention: SPACE
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional endoscopy
Number of subjects: 20
Study: 19121451

Group type: EXPERIMENTAL
Intervention: Nebivolol monotherapy
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Nebivolol plus diuretic
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Nebivolol plus calcium channel blocker
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Nebivolol plus other antihypertensive medication
Number of subjects: 845